IGF-IR signaling attenuates the age-related decline of diastolic cardiac function.

Insulin-like growth factor (IGF-I) signaling has been implicated to play an important role in regulation of cardiac growth, hypertrophy, and contractile function and has been linked to the development of age-related congestive heart failure. Here, we address the question to what extent cardiomyocyte-specific IGF-I signaling is essential for maintenance of the structural and functional integrity of the adult murine heart. To investigate the effects of IGF-I signaling in the adult heart without confounding effects due to IGF-I overexpression or adaptation during embryonic and early postnatal development, we inactivated the IGF-I receptor (IGF-IR) by a 4-hydroxytamoxifen-inducible Cre recombinase in adult cardiac myocytes. Efficient inactivation of the IGF-IR (iCMIGF-IRKO) as assessed by Western analysis and real-time PCR went along with reduced IGF-I-dependent Akt and GSK3β phosphorylation. Functional analysis by conductance manometry and MRI revealed no functional alterations in young adult iCMIGF-IRKO mice (age 3 mo). However, when induced in aging mice (11 mo) diastolic cardiac function was depressed. To address the question whether insulin signaling might compensate for the defective IGF-IR signaling, we inactivated β-cells by streptozotocin. However, the diabetes-associated functional depression was similar in control and iCMIGF-IRKO mice. Similarly, analysis of the cardiac gene expression profile on 44K microarrays did not reveal activation of overt adaptive processes. Endogenous IGF-IR signaling is required for conservation of cardiac function of the aging heart, but not for the integrity of cardiac structure and function of young hearts.

[1]  F. Weinberger,et al.  Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice , 2012, Journal of molecular and cellular cardiology.

[2]  M. Reinartz,et al.  β-Adrenergic signaling and response to pressure overload in transgenic mice with cardiac-specific overexpression of inducible NO synthase. , 2011, Nitric oxide : biology and chemistry.

[3]  K. Köhrer,et al.  Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. , 2010, Physiological genomics.

[4]  M. Vinciguerra,et al.  Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity , 2009, Aging.

[5]  P. Hildebrandt,et al.  Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[6]  Christian Andresen,et al.  Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs , 2008, Circulation research.

[7]  D. Leroith,et al.  Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. , 2008, Molecular endocrinology.

[8]  Linda Koch,et al.  Epidermal insulin/IGF‐1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation , 2008, The EMBO journal.

[9]  Brad T. Sherman,et al.  The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.

[10]  N. Rosenthal,et al.  Enhancing Repair of the Mammalian Heart , 2007, Circulation research.

[11]  C. Stewart,et al.  Apoptosis and the cardiac action of insulin-like growth factor I. , 2007, Pharmacology & therapeutics.

[12]  O. Osadchii.  Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects , 2007, Heart Failure Reviews.

[13]  Jun Ren,et al.  Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. , 2007, American journal of physiology. Heart and circulatory physiology.

[14]  C. Kahn,et al.  Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function , 2006, Molecular and Cellular Biology.

[15]  A. Gödecke,et al.  Detection of TAP-tagged proteins in Western blot, confocal laser scanning microscopy and FACS using the ZZ-domain. , 2006, Journal of biochemical and biophysical methods.

[16]  L. Schäffer,et al.  Hybrid Receptors Formed by Insulin Receptor (IR) and Insulin-like Growth Factor I Receptor (IGF-IR) Have Low Insulin and High IGF-1 Affinity Irrespective of the IR Splice Variant* , 2006, Journal of Biological Chemistry.

[17]  J. Molkentin,et al.  Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.

[18]  A. Hofman,et al.  A promoter polymorphism of the insulin-like growth factor-I gene is associated with left ventricular hypertrophy , 2005, Heart.

[19]  A. Hofman,et al.  Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study). , 2004, The American journal of cardiology.

[20]  Yiming Wu,et al.  Altered Titin Expression, Myocardial Stiffness, and Left Ventricular Function in Patients With Dilated Cardiomyopathy , 2004, Circulation.

[21]  Ralph D'Agostino,et al.  Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study , 2003, Annals of Internal Medicine.

[22]  U. Flögel,et al.  Myoglobin Protects the Heart from Inducible Nitric-oxide Synthase (iNOS)-mediated Nitrosative Stress* , 2003, Journal of Biological Chemistry.

[23]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[24]  P. Doevendans,et al.  Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. , 2001, Cardiovascular research.

[25]  R. Hammer,et al.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.

[26]  J. Schrader,et al.  Adaptive mechanisms of the cardiovascular system in transgenic mice – lessons from eNOS and myoglobin knockout mice , 2000, Basic Research in Cardiology.

[27]  D. Leroith,et al.  Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth. , 2000 .

[28]  R. Schwartz,et al.  Local insulin‐like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  U. Flögel,et al.  Disruption of myoglobin in mice induces multiple compensatory mechanisms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Reth,et al.  Comparison of the Tamoxifen Regulated Chimeric Cre Recombinases MerCreMer and CreMer , 1999, Biological chemistry.

[31]  K. Siddle,et al.  Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. , 1997, The Biochemical journal.

[32]  J. Ross,et al.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. , 1996, The Journal of clinical investigation.

[33]  B. Li,et al.  Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[35]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[36]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[37]  M. Rechler,et al.  Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. , 1992, Molecular endocrinology.

[38]  L. Murphy,et al.  Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat , 1991, Molecular and Cellular Biochemistry.

[39]  H. Vliegen,et al.  Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation. , 1991, European heart journal.

[40]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[41]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[42]  U. Flögel,et al.  Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice , 2005, Basic Research in Cardiology.